Psomagen, a CLIA-certified genetic analysis provider, is expanding its at-home testing services to include routine women’s health screening. This move began with The VProject, which is recruiting 1,000 women aged 18 and older in the United States to participate in a vaginal microbiome research study. For their involvement, participants receive a no-cost personalized test of their vaginal microbiome which can be used to…
Vulvovaginal Atrophy (VVA) is a condition that results from a decrease in the body’s estrogen levels. Symptoms of VVA can include vaginal soreness, irritation, and pain. Research has indicated that the condition affects at least half of all post-menopausal women and breast cancer survivors, many of whom often report substantive reductions in quality of life. The condition may be widely underdiagnosed and undertreated. Symptoms…
Cleveland-based Renalis has raised a $824K pre-seed round led by the Healthcare Collaboration Fund, which is managed through a partnership betweent JumpStart and University Hospitals Ventures. Renalis is a digital health company that creates platforms to improve experiences and outcomes for people with pelvic health conditions. Designed to tackle the biggest challenges in pelvic health management, Renalis platforms increase patient engagement, improve…
Hologic’s Acessa procedure is now covered by Anthem Blue Cross Blue Shield, the second largest health plan in the United States. Anthem has updated its medical policy to cover Radiofrequency Ablation (LAP-RFA), which includes the Acessa procedure for women suffering from uterine fibroids. The updated policy creates access to uterine-preserving care for Anthem’s approximately 40 million members in all 50 states, providing…
LiNA Medical USA and FEMSelect have announced the U.S. launch of FEMSelect’s EnPlace pelvic floor ligament fixation system. The EnPlace patented delivery system enables the precise guidance, insertion and deployment of a small, nitinol anchor for pelvic floor ligament fixation. The approach is performed with minimal dissection and no mesh. This nationwide launch will now enable access to the technology across the US for both pelvic…
Leading UK-based femtech company Elvie has just announced the closing of a £58M Series C. The round was led by BFG with participation from funds and accounts managed by BlackRock, a consortium including Hiro Capital and Westerly Winds, Octopus Ventures and PPGL. Elvie was founded in 2013 by Tania Boler. Its current product line-up includes Elvie Trainer, an app-connected Kegel trainer, Elvie…
Pelvital, a privately held medical device company that has developed Flyte, a clinically proven, FDA-cleared, non-surgical treatment for female stress urinary incontinence (SUI), announced today that Ryan Willemsen has been appointed Chief Operations Officer. In this role, Willemsen will be responsible for leading the operations of Pelvital with a focus on market adoption of Flyte, building a global sales and distribution capability,…
Women’s health startup Stix now offers a comprehensive suite of products for yeast infections. According to the company 75% of women will have at least one yeast infection in their lifetime. Stix was founded in 2019 and started out selling pregnancy and ovulation tests. Co-founders Cynthia Plotch and Jamie Norwood met through the Venture for America fellowship. After spending nights and weekends researching…
